Simulation-Based Planning of ALS Trials

<p><span data-sheets-value= "{"1":2,"2":"Dr. Gordon Smith talks with Drs. Ruben P.A. van Eijk and Jordi van Unnik about the planning of interim analyses for clinical trials in ALS to maximize patient safety and minimize exposure to ineffective or harmful drugs.\n\nRead the related article in Neurology. \n\nVisit NPUb.org/Podcast for associated article links."}" data-sheets-userformat= "{"2":13251,"3":{"1":0},"4":{"1":2,"2":14277081},"9":1,"10":1,"11":4,"12":0,"15":"Calibri","16":13}"> Drs. Ruben P.A. van Eijk and Jordi van Unnik discuss the planning of interim analyses for clinical trials in ALS to maximize patient safety and minimize exposure to ineffective or harmful drugs.<br /> <br /> Show references: https://n.neurology.org/content/100/23/e2398</span></p>